Welcome to our dedicated page for Maximus SEC filings (Ticker: MMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Maximus, Inc. (NYSE: MMS) SEC filings page on Stock Titan provides access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. Maximus is a government services and technology company that reports its results and material events through periodic and current reports, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. These documents cover topics such as segment performance across U.S. Federal Services, U.S. Services, and Outside the U.S., contract activity, capital allocation decisions, and risk disclosures.
Investors can use this page to review Maximus filings that discuss revenue drivers like clinical programs and tech-enabled service delivery, as well as information on operating margins, adjusted EBITDA, and free cash flow as described in the company’s non-GAAP reconciliations. Current reports on Form 8-K include items such as earnings releases, updates to stock purchase programs authorized by the Board of Directors, and certain leadership changes. For example, recent 8-K filings have covered financial results for specific periods, an increase to the stock purchase program authorization, and the planned resignation of a senior legal officer.
Stock Titan enhances these filings with AI-powered summaries that explain key points in clear language, helping readers understand complex sections of lengthy 10-K and 10-Q reports. Real-time updates from the SEC’s EDGAR system ensure that new Maximus filings, including Forms 3, 4, and 5 related to insider transactions, appear promptly on this page. Users can quickly identify when executives or directors report trades in MMS stock through Form 4 filings.
Whether you are looking for the latest annual report, quarterly results, details on capital deployment such as dividends and stock purchase programs, or specific 8-K disclosures about material events, this page offers a structured view of Maximus’ regulatory history, supported by AI summaries that highlight the most important information for analysis.
Maximus Inc Schedule 13G shows Vanguard Capital Management beneficially owns 2,857,086 shares of Common Stock, representing 5.23% of the class. The filing states Vanguard has sole voting power over 419,450 shares and sole dispositive power over 2,857,086 shares. The Schedule 13G lists affiliated Vanguard entities in its explanatory comment and is signed on 04/30/2026.
Maximus Inc reported that Vanguard Portfolio Management beneficially owned 3,523,165 shares of Common Stock, representing 6.45% of the class as of 03/31/2026. The filing states Vanguard exercises sole dispositive power over those shares and discloses that ownership is held on behalf of multiple Vanguard-managed accounts and funds.
MAXIMUS, INC. reported initial insider holdings for General Counsel and Corporate Secretary Elizabeth Moellering. She directly holds 5,044.166 shares of common stock. Footnotes describe prior equity awards of restricted stock units that vest over multiple years, each representing the right to receive one share of common stock.
Moellering was granted 1,232 RSUs on April 1, 2024, 1,361 RSUs on November 25, 2024, and 2,850 RSUs on November 24, 2025, each vesting ratably over four years on specified September 30 vesting dates. Dividend equivalent rights accrue on these RSUs when dividends are paid on the common stock.
The Vanguard Group filed an amended Schedule 13G/A reporting beneficial ownership in Maximus Inc. The amendment states Vanguard and its reporting entities hold 0 shares of Maximus common stock, representing 0% of the class. The filing explains an internal realignment and disaggregation of certain Vanguard subsidiaries for SEC reporting purposes.
MAXIMUS, INC. director Jan Madsen reported an open-market sale of 742 shares of Common Stock at $72.25 per share. The transaction took place on March 17, 2026 and was made under a Rule 10b5-1 trading plan adopted on September 14, 2024.
Following this sale, Madsen directly holds 20,794.822 shares of MAXIMUS Common Stock. A 10b5-1 trading plan means the sale was pre-scheduled in advance, which typically indicates a routine approach to liquidity rather than a discretionary trade based on recent company developments.
Madsen Jan reported acquisition or exercise transactions in this Form 4 filing.
MAXIMUS, INC. director Jan Madsen received an equity grant of 3,215 shares of Common Stock in the form of restricted stock units on March 10, 2026. These RSUs vest one year from the grant date, reflecting routine director compensation rather than an open-market purchase.
Madsen elected to defer receipt of the underlying common stock until service on the board ends. Following this grant, direct holdings reported in Common Stock total 21,536.822 shares, which include 65.219 dividend-equivalent rights accrued on previously awarded RSUs.
HALEY JOHN J reported acquisition or exercise transactions in this Form 4 filing.
MAXIMUS, INC. director John J. Haley received an equity grant of 7,009 restricted stock units, a form of stock-based compensation. These RSUs vest one year from the grant date, and he has elected to defer receiving the common shares until his service on the board ends.
Following this grant, he holds 47,115.951 shares of common stock directly. He also has indirect holdings of 71,132 shares through the John J. Haley Grantor Retained Annuity Trust Seven and 32,764 shares through the John J. Haley Grantor Retained Annuity Trust Eight. The position includes 135.462 dividend equivalent rights that vest alongside earlier RSU awards.
Altman Anne K. reported acquisition or exercise transactions in this Form 4 filing.
MAXIMUS, INC. director Anne K. Altman reported receiving an equity award of 3,062 shares of Common Stock at no cash cost, characterized as a grant or award. This represents restricted stock units that vest one year from the grant date and include 13.83 dividend-equivalent rights tied to earlier RSU awards.
After this grant, Altman directly holds a total of 35,141.897 shares. The transaction is compensation-related rather than an open-market purchase or sale, so it reflects routine director remuneration instead of a change in personal trading stance.
Warren Michael J. reported acquisition or exercise transactions in this Form 4 filing.
MAXIMUS, INC. director Michael J. Warren reported an award of 2,246 shares of Common Stock in the form of restricted stock units. These RSUs vest one year from the grant date, effectively adding to his equity-based compensation. Following this award and prior dividend-related adjustments, he holds 17,839.316 shares directly, reflecting both granted units and shares accumulated through dividend equivalents and reinvestment.